Scienture Holdings (FRA:4E4) Cyclically Adjusted Revenue per Share: €3.41 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:4E4 Scienture Holdings Inc FRA:4E4
47 GF Score
Price €0.17
GF Value €0.16
! 6 Warning Signs
View Full Analysis

What is Scienture Holdings Cyclically Adjusted Revenue per Share?

Scienture Holdings FRA:4E4 -7.09% 47 Cyclically Adjusted Revenue per Share is €3.41 as of Mar. 2026. GuruFocus rates FRA:4E4 with a GF Score™ of 47/100 and a GF Value™ of €0.16. The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Scienture Holdings's adjusted revenue per share for the three months ended in Mar. 2026 was €0.001. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €3.41 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Scienture Holdings's average Cyclically Adjusted Revenue Growth Rate was -1.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -32.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -26.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Scienture Holdings was -1.50% per year. The lowest was -32.50% per year. And the median was -32.15% per year.

As of today (2026-07-29), Scienture Holdings's current stock price is €0.173. Scienture Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €3.41. Scienture Holdings's Cyclically Adjusted PS Ratio of today is 0.05.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Scienture Holdings was 2.67. The lowest was 0.02. And the median was 0.50.


Scienture Holdings  (FRA:4E4) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Scienture Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.173/3.41
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Scienture Holdings was 2.67. The lowest was 0.02. And the median was 0.50.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Scienture Holdings Cyclically Adjusted Revenue per Share Related Terms


Scienture Holdings Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Scienture Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scienture Holdings Cyclically Adjusted Revenue per Share Chart

Scienture Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.59 0.01 19.91 17.35 8.31

Scienture Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.54 0.00 9.79 8.31 3.41

FRA:4E4 vs HEWA, BLMH, PMHS: Cyclically Adjusted Revenue per Share Comparison

For the Pharmaceutical Retailers subindustry, Scienture Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scienture Holdings Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Scienture Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Scienture Holdings's Cyclically Adjusted PS Ratio falls into.


FRA:4E4
47GF Score
Scienture Holdings Inc FRA:4E4
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scienture Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Scienture Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.001/330.2130*330.2130
=0.001

Current CPI (Mar. 2026) = 330.2130.

Scienture Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 1.494 241.018 2.047
201609 1.550 241.428 2.120
201612 1.719 241.432 2.351
201703 1.832 243.801 2.481
201706 1.766 244.955 2.381
201709 1.631 246.819 2.182
201712 1.763 246.524 2.361
201803 1.831 249.554 2.423
201806 1.872 251.989 2.453
201809 1.881 252.439 2.461
201812 2.871 251.233 3.774
201903 3.348 254.202 4.349
201906 4.198 256.143 5.412
201909 5.206 256.759 6.695
201912 3.508 256.974 4.508
202003 4.028 258.115 5.153
202006 11.594 257.797 14.851
202009 9.993 260.280 12.678
202012 3.035 260.474 3.848
202103 4.750 264.877 5.922
202106 2.911 271.696 3.538
202109 3.985 274.310 4.797
202112 3.884 278.802 4.600
202203 5.398 287.504 6.200
202206 5.692 296.311 6.343
202209 3.763 296.808 4.187
202212 3.430 296.797 3.816
202303 0.686 301.836 0.750
202306 0.498 305.109 0.539
202309 0.155 307.789 0.166
202312 0.045 306.746 0.048
202403 0.000 312.332 0.000
202406 0.013 314.175 0.014
202409 0.025 315.301 0.026
202412 0.006 315.605 0.006
202503 0.001 319.799 0.001
202506 0.000 322.561 0.000
202509 0.027 324.800 0.027
202512 -0.008 324.054 -0.008
202603 0.001 330.213 0.001

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €3.41 mean?
Scienture Holdings (FRA:4E4) has a Cyclically Adjusted Revenue per Share of €3.41 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Scienture Holdings and its competitors.
Is Scienture Holdings' Cyclically Adjusted Revenue per Share too high?
Scienture Holdings' current Cyclically Adjusted Revenue per Share is €3.41. Overall, Scienture Holdings has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Scienture Holdings' Cyclically Adjusted Revenue per Share compare to HEWA and BLMH?
Scienture Holdings' Cyclically Adjusted Revenue per Share of €3.41 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Scienture Holdings and its competitors. Scienture Holdings's current Cyclically Adjusted Revenue per Share is €3.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scienture Holdings stock overvalued right now?
Scienture Holdings (FRA:4E4) has a current Cyclically Adjusted Revenue per Share of €3.41. The stock's GF Value™ is €0.16, compared to a current price of €0.17 — trading 8.1% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €3.41. Scienture Holdings' overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Scienture Holdings (FRA:4E4), the current Cyclically Adjusted Revenue per Share is €3.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scienture Holdings (FRA:4E4) Overvalued in 2026?

Based on GuruFocus' analysis, Scienture Holdings stock appears to be overvalued. The current stock price of €0.17 is trading 8.1% above its estimated GF Value™ of €0.16.

Key valuation signals for FRA:4E4:

  • Cyclically Adjusted Revenue per Share: €3.41
  • GF Value™: €0.16 vs. price of €0.17 (8.1% above fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the FRA:4E4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scienture Holdings Business Description

Other Exchanges SCNX:USA
Address 20 Austin Boulevard, Commack, NY, USA, 11725
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
47GF Score

Get the complete analysis for FRA:4E4

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.17
Price
€0.16
GF Value